Patent ID: 7816356
Filing Date: 2010-10-19
Classification: A61K

Abstract:
1. A pharmaceutical composition comprising a compound selected from the group consisting of: h) 2,3,3a,7b-tetrahydro-1H-benzo[3,4]cyclobuta[1,2-c]pyrrole; l) 5-nitro-2,3,3a,7b-tetrahydro-1H-benzo[3,4]cyclobuta[1,2-c]pyrrole; p) 6,7,8,8a-tetrahydro-5bH-pyrrolo[3′,4′:3,4]cyclobuta[1,2-g]quinoxaline; r) 2,3-dimethyl-6,7,8,8a-tetrahydro-5bH-pyrrolo[3′,4′:3,4]cyclobuta[1,2-g]quinoxaline; v) 5-chloro-2,3,3a,7b-tetrahydro-1H-benzo[3,4]cyclobuta[1,2-c]pyrrole.